TMS Philadelphia, OCD Therapy Philadelphia

Can Visiting a TMS Doctor Benefit You?

Depression Help Philadelphia, TMS therapy Philadelphia

If you have struggled with depression but have had no relief from pills or therapy, it’s easy to feel discouraged. Thankfully, Transcranial Magnetic Stimulation, also known as TMS, is best suited for those who have not seen relief from traditional forms of depression treatment. TMS has been around for a while, but if you’ve never heard of it before, you may be wondering if it’s right for you. 

Depression Help Philadelphia

Why should you see a TMS Doctor today? 

  1. TMS has little to no side effects. Unfortunately, many antidepressant medications have multiple side effects. With TMS therapy, you will most likely not experience any side effects. Mild headaches are a common side effect, but they tend to go away as you continue treatment. TMS is often recommended to patients who cannot handle the side effects of their oral antidepressant medication. 
  2. The treatment is safe and FDA-approved. TMS is non-invasive and has little to no side effects making it a safe option for patients. Many patients report that TMS is more effective and convenient when compared to other forms of treatment tried. 
  3. Your insurance should cover the cost. Since the majority of insurance companies cover TMS treatment, it is a cost-effective option. Whether you’re insured by Medicaid or Medicare, or a private company, you should have all or most of your treatments covered. Talk with both your doctor and your health insurance company before you begin treatment to know your costs. 

Do not suffer from depression any longer. Give us a call today for the best depression therapy in Philadelphia

Related Reading
Copyright © 2019 Spark TMS Therapeutic Center. All Rights Reserved.
Looking for TMS Philadelphia & Depression Help Philadelphia? Then you have come to the right place. Now Brainsway TMS is FDA cleared for OCD. The TMS protocol offered at Spark TMS is established for the patient under the direct supervision of Andrew Peshek, M.D.